YS Alpha Tablet 1 Microgram (Alfacalcidol)

Adult dose

Chronic kidney failure/Osteoporosis: 0.5 to 1 µg orally once daily as alfacalcidol. Hypoparathyroidism and other diseases related to vitamin D metabolism disorders: 1 to 4 µg orally once daily as this medication.

Child dose

Osteoporosis: 0.01 to 0.03 µg per kg body weight orally once daily as alfacalcidol. Other conditions: 0.05 to 0.1 µg per kg body weight orally once daily as this medication.

This medication should not be taken by patients with hypercalcemia, hyperphosphatemia, or hypermagnesemia, where the levels of calcium and phosphorus in the blood are abnormally high. Patients with blood calcium and phosphorus product exceeding specific levels or those with metabolic alkalosis, which causes the blood to become alkaline, should not take this medication. Patients showing signs of vitamin D toxicity or those allergic to any components in this medication should avoid using it. During the course of this medication, magnesium-containing drugs, vitamin D and its derivatives, calcium-containing preparations, or certain diuretics, which may increase the risk of hypercalcemia, should not be taken together. Breastfeeding women should avoid using this medication due to uncertainty regarding its safety, and if necessary, discontinuing breastfeeding is advisable. Women who are pregnant or may become pregnant should consult a physician, as it may be harmful to the fetus. Children, elderly patients, those on specific medications, patients with a history of kidney stones, or sarcoidosis should consult a healthcare professional before using this medication. During the use of this medication, gastrointestinal disturbances, neurological or psychiatric issues, heart problems, renal function decline, liver function abnormalities, skin rashes, visual disturbances, etc. may occur. If any abnormal symptoms appear, discontinue use immediately and consult a professional. Excessive dosage may lead to severe hypercalcemia, therefore, serum calcium levels should be regularly monitored, and the dosage adjusted accordingly. Strict dietary management and calcium intake are necessary to prevent symptoms of hypercalcemia and prompt action should be taken in case of any abnormal symptoms.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, high fever with severe rash, blisters, peeling skin, painful mucous membranes of the mouth/eyes, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, liver issues (jaundice), sudden

Mild side effects

• Loss of appetite
• nausea
• vomiting
• diarrhea
• constipation
• stomach pain
• discomfort in the upper abdomen
• bloating
• indigestion
• thirst

This medicine may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to keep it at room temperature between 1°C to 30°C. This will help maintain the efficacy of the medication for a longer period.

Appearance

White round tablet

Package unit

Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle